Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 11|pp. 10074–10107
Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
Back to articleFigure 3(3 of 6)
100%
Figure 3
Figure 3.Correlation between ImmuneScore and SMARCD3 expression in 5 cancers. (A) COAD; (B) DLBC; (C) PRAD; (D) READ; (E) SRAC.
Figure 3 — Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3 | Aging